Masahiro Yoshioka

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A case of ER-positive, HER2-negative metastatic breast cancer with high tumor mutation burden achieving complete response to pembrolizumab monotherapy.

A case of ER-positive, HER2-negative metastatic breast cancer with high tumor mutation burden achieving complete response to pembrolizumab monotherapy.

Journal: International cancer conference journal

Published: November 18, 2025

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study.

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study.

Journal: Cancer science

Published: December 01, 2024

Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy.

Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy.

Journal: Journal of human genetics

Published: June 17, 2024

Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion.

Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion.

Journal: International cancer conference journal

Published: November 15, 2023

Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification.

Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification.

Journal: International cancer conference journal

Published: September 20, 2023

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

Journal: JAMA network open

Published: July 17, 2023

Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Journal: International journal of clinical oncology

Published: April 27, 2022

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.

Journal: International journal of clinical oncology

Published: February 10, 2022

Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.

Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.

Journal: Journal of human genetics

Published: February 02, 2022

From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology

From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 16, 2021

Inter-assay variability of next-generation sequencing-based gene panels.

Inter-assay variability of next-generation sequencing-based gene panels.

Journal: BMC medical genomics

Published: July 15, 2021

Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy.

Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 27, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026